{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:07:14Z","timestamp":1775480834487,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,16]]},"abstract":"<jats:p>Low-dose aspirin administration before 16 weeks of gestation can prevent preeclampsia (PE) more effectively. In order to determine if aspirin should be administered, this study aimed to investigate the predictive value of pregnancy-associated plasma protein A (PAPP-A) and aneuploidy markers for the onset period of PE. 1053 singleton pregnant women were included in the study, and serum PAPPA-A and aneuploidy markers were analyzed between 3 group (normotensive, late-onset PE, and early-onset PE). The utility of these markers for predicting early-onset preeclampsia (EOPE) was compared using each marker and their combination. Alpha-fetoprotein (AFP)\/PAPP-A\u2005&gt;\u20056.89 and human chorionic gonadotropin (hCG)\/PAPP-A\u2005&gt;\u20057.94 were associated with EOPE with a positive likelihood ratio (LR) (6.52, 95% confidence interval [CI] 4.9\u20137.1), and (5.77, 95% CI 3.9\u20136.4). The combination of markers could predict EOPE more accurately compared to the single markers. AFP\/PAPP-A\u2005&gt;\u20056.89 and hCG\/PAPP-A\u2005&gt;\u20057.94had a predictive ability for EOPE, and these cutoff values can help determine the use of aspirin at an earlier gestational age (GA).<\/jats:p>","DOI":"10.1097\/md.0000000000032319","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T14:06:17Z","timestamp":1671717977000},"page":"e32319","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic efficacy of aneuploidy markers correlated with early onset preeclampsia"],"prefix":"10.1097","volume":"101","author":[{"given":"Seung Yeon","family":"Pyeon","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Su","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-7368","authenticated-orcid":false,"given":"Young Joo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40885-021-00188-w","article-title":"Korea hypertension fact sheet 2021: analysis of nationwide population-based data with special focus on hypertension in women","volume":"28","author":"Kim","year":"2022","journal-title":"Clin Hypertens"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/IJWH.S8550","article-title":"Diagnosis and management of pre-eclampsia: an update","volume":"2","author":"Turner","year":"2010","journal-title":"Int J Womens Health"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5468\/ogs.2020.63.3.270","article-title":"A study to compare maternal and perinatal outcome in early vs. late onset preeclampsia","volume":"63","author":"Wadhwani","year":"2020","journal-title":"Obstet Gynecol Sci"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/HYPERTENSIONAHA.108.117358","article-title":"Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease","volume":"52","author":"Valensise","year":"2008","journal-title":"Hypertension"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","article-title":"A critical review of early-onset and late-onset preeclampsia","volume":"66","author":"Raymond","year":"2011","journal-title":"Obstet Gynecol Surv"},{"issue":"Suppl","key":"R8-20250504","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0038-1660777","article-title":"Uterine artery doppler in screening for preeclampsia and fetal growth restriction","volume":"40","author":"Pedroso","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R12-20250504","first-page":"6435","article-title":"Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR","volume":"17","author":"Sifakis","year":"2018","journal-title":"Mol Med Rep"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","article-title":"First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes","volume":"115","author":"Dugoff","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7754\/Clin.Lab.2016.161103","article-title":"Maternal serum PLGF, PAPPA, \u03b2-hCG and AFP levels in early second trimester as predictors of preeclampsia","volume":"63","author":"Duan","year":"2017","journal-title":"Clin Lab"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20250504","first-page":"1","article-title":"ACOG practice bulletin No. 202 summary: gestational hypertension and preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"812","DOI":"10.24953\/turkjped.2020.05.013","article-title":"Neonatal outcomes of early- and late-onset preeclampsia","volume":"62","author":"B\u00fcy\u00fckeren","year":"2020","journal-title":"Turk J Pediatr"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1701-2163(15)30331-5","article-title":"Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes","volume":"37","author":"Tancr\u00e8de","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1525-1497.2002.10750.x","article-title":"Simplifying likelihood ratios","volume":"17","author":"McGee","year":"2002","journal-title":"J Gen Intern Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/L14-5020-5","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia","volume":"161","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/humrep\/17.3.794","article-title":"Maternal serum beta-HCG and alpha-fetoprotein concentrations in singleton pregnancies following assisted reproduction","volume":"17","author":"Perheentupa","year":"2002","journal-title":"Hum Reprod"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3892\/br.2016.611","article-title":"Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies","volume":"4","author":"Ren","year":"2016","journal-title":"Biomed Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:17:56Z","timestamp":1746332276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":25,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032319","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]}}}